$CYPH 3 SEC Filings

Filed On	Filing
25 Sep 2026	Form 3: Fabiano Amanda, Director
24 Aug 2026	Form 3: Zhang Kevin, Head of Mining Holds 330,904 shares of Common Stock
21 Nov 2025	Form 3: Winklevoss Capital Fund, Llc, 10% owner and 4 others Holds 8,283,761 shares of Common Stock
20 Nov 2025	Form 3: McEvoy William Patrick Iii, Director Holds 8,283,761 shares of Common Shares
13 Nov 2025	Form 3: Oei Khing Djien, Director No securities owned
19 Apr 2024	Form 3: Gilead SCIENCES, Inc., 10% owner Holds 5,319,148 shares of Common Stock
03 Apr 2023	Form 3: Baum Jason, Chief Scientific Officer
25 Jan 2023	Form 3: Martin Patricia A., Director No securities owned
25 Jan 2023	Form 3: Richard Christian M, Director No securities owned
08 Sep 2022	Form 3: Schilsky Richard, Director No securities owned
21 Aug 2020	Form 3: Granfield Christine, VP, Head of Reg Affairs/Qual
20 Apr 2020	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 6,726,496 shares of Common Stock
06 Apr 2020	Form 3: Sirard Cynthia, Chief Medical Officer
06 Apr 2020	Form 3: O'Mahony John Mark, Chief Manufacturing Officer
23 Mar 2020	Form 3: BeiGene, Ltd., 10% owner Holds 4,804,637 shares of Common Stock
14 Dec 2018	Form 3: Bertagnolli Monica, Director No securities owned
16 Nov 2017	Form 3: Lilly Eli & Co, 10% owner Holds 1,479,307 shares of Common Stock
24 Feb 2017	Form 3: HealthCare Ventures IX, L.p., 10% owner and 1 other Holds 2,515,607 shares of Common Stock
25 Jan 2017	Form 3: Li William, Director No securities owned
23 Jan 2017	Form 3: Lawlor Augustine, Chief Operating Officer Holds 5,477,902 shares of Common Stock

Comments